Abstract
Clozapine is an antipsychotic drug with few extra-pyramidal motor side-effects, used to treat schizophrenia which is resistant to classical neuroleptic therapy. This report shows that norclozapine but not clozapine-N-oxide has the same D2 receptor affinity as clozapine. Assay results suggest a bimodal distribution which may be explained by CYP1A2 polymorphism. Extensive metabolizers could produce other active metabolites, probably other hydroxy-clozapine derivatives.
MeSH terms
-
Animals
-
Antipsychotic Agents / blood*
-
Antipsychotic Agents / therapeutic use
-
Chromatography, High Pressure Liquid
-
Clozapine / analogs & derivatives
-
Clozapine / blood*
-
Clozapine / therapeutic use
-
Corpus Striatum / metabolism
-
Female
-
Humans
-
Hydroxylation
-
Male
-
Radioligand Assay
-
Rats
-
Receptors, Dopamine D2 / metabolism
-
Schizophrenia / blood*
-
Schizophrenia / drug therapy
Substances
-
Antipsychotic Agents
-
Receptors, Dopamine D2
-
norclozapine
-
Clozapine
-
clozapine N-oxide